We have put together the top 10 slides from our Pharma Pricing & Market Access Outlook Europe 2013 presentations. All of these slides were part of in-depth, informative presentations given by industry professionals, addressing the critical policy issues in developing the optimum pricing strategy for pharmaceutical products.
Top presentations included:
- Three vital areas for improving market access
- Scarcity,value and price
- Oncology: A special case for HTA?
- Market Access for orphan drugs in EU